Washington, DC (PRWEB) November 9, 2007 -- Shire plc (www.shire.com) (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, yesterday announced results of a national survey where 60 percent of 121 mothers reported their 6 to 12 year old child?s once-daily Attention Deficit Hyperactivity Disorder (ADHD) medication stopped working before 6 p.m. The survey findings report the perceptions of 500 parents of children with ADHD regarding the duration of effectiveness of their child?s once-daily stimulant or non-stimulant ADHD medication and were presented yesterday at the 2007 Children and Adults with Attention-Deficit Hyperactivity Disorder (CHADD) Annual Conference.
This survey was conducted via Internet interviews of 249 parents of children with ADHD aged 6 to 12 years (125 took stimulant medications and 124 children took non-stimulant medications) and 251 parents of adolescents aged 13 to 17 years (126 took stimulant medications and 125 took non-stimulant medications). The children of the surveyed parents took their ADHD medication once daily in the morning.
Results of the survey found that among the 249 parents of children aged 6 to12 with ADHD, a majority of those children take their ADHD medication between 6 a.m. and 8 a.m. Among 219 parents with children taking ADHD stimulant medications, 70 percent said that their child?s medication lasted 11 hours or less.
Additionally, more than half of parents of children with ADHD aged 6 to 12 reported that their child?s medication stopped working before 6 p.m.
?These survey results illustrate that parents may not see their children?s ADHD medications working until 6 p.m.,? said Robert Findling, M.D., lead author of the survey and Professor of Psychiatry at Case Western Reserve University and Director of the Division of Adolescent and Child Psychiatry at University Hospitals Case Medical Center. ?This may be important because ADHD doesn?t only impact a child?s school performance but can also impact interactions with friends, coaches, and other family members.?
This survey was supported by Shire plc (www.shire.com).
About ADHD
Approximately 7.8 percent of all school-age children, or about 4.4 million U.S. children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the U.S. Centers for Disease Control and Prevention (CDC). ADHD is one of the most common psychiatric disorders in children and adolescents. The disorder is also estimated to affect 8.1 percent of adults, or approximately 9.2 million adults across the U.S. based on a retrospective survey of adults aged 18 to 44, projected to the full U.S. adult population. ADHD is a neurobiological disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of development. To be properly diagnosed with ADHD, a child needs to demonstrate at least six of nine symptoms of inattention; and/or at least six of nine symptoms of hyperactivity/impulsivity; the onset of which appears before age 7 years; that some impairment from the symptoms is present in two or more settings (e.g., at school and home); that the symptoms continue for at least six months; and that there is clinically significant impairment in social, academic or occupational functioning and the symptoms cannot be better explained by another psychiatric disorder.
Although there is no ?cure? for ADHD, there are accepted treatments that specifically target its symptoms. The most common standard treatments include educational approaches, psychological or behavioral modification, and medication.
For further information please contact:
Porter Novelli for Shire
Lucia Lodato
212-601-8037
917-617-3058 (on site at CHADD)
Brooke Salti
212-601-8241
Poster Information
Parental Perceptions of the Duration of Effectiveness of Prescription Medications used to treat Attention-Deficit Hyperactivity Disorder in Children and Adolescents
November 8, 2007; 4:30 ? 6:30 p.m. EDT
SHIRE PLC
Shire?s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire?s in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
For further information on Shire, please visit the Company?s website: www.shire.com
THE ?SAFE HARBOR? STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire?s results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research; product development including, but not limited to, the successful development of JUVISTA® (Human TGF²3) and GA-GCB (velaglucerase alfa); manufacturing and commercialization including, but not limited to, the launch and establishment in the market of VYVANSE? (lisdexamfetamine dimesylate) (Attention Deficit and Hyperactivity Disorder (?ADHD?)); the impact of competitive products including, but not limited to, the impact of those on Shire?s ADHD franchise; patents including, but not limited to, legal challenges relating to Shire?s ADHD franchise; government regulation and approval including, but not limited to, the expected product approval date of INTUNIV? (guanfacine extended release) (ADHD); Shire?s ability to secure new products for commercialization and/or development; and other risks and uncertainties detailed from time to time in Shire plc?s filings with the Securities and Exchange Commission, particularly Shire plc?s Annual Report on Form 10-K for the year ended December 31, 2006.
# # #
What Is Attention Deficit Hyperactivity Disorder?
Attention Deficit Hyperactivity Disorder is a medical condition. It is caused by genetic factors that result in certain neurological differences.
Common Add Adhd Checklist Signs
Does you child show signs of being impulsive, hyperactive and inattentive? Then he or she might be showing some symptoms of ADHD. If you are concerned about your child?s behavior then checking the common signs and symptoms on an ADD/ADHD checklist can help to determine if further assessment is needed.
Dexedrine, Cylert, and Adderall in the Treatment of ADHD
Dexedrine is not prescribed very often for the treatment of ADHD out here in California, but those patients that we've seen on it have done well. Typically it is prescribed to patients who have not responded to Ritalin very well.
Maximizing Your ADHD Childs Performance in School.
As a parent there are lots of things that you can do to help your child with ADHD succeed in school, with friends, and in life. Here are some tips for you that just may help you in your ongoing efforts to help your child.
ADHD; A life saver
Studying the characteristics of ADHD; one would have to say that it might not be a negative trait at all. As a matter of fact squirrels and other fidgety creatures are able to stay more alert and not get eaten by predators as often as other critters.
Adult ADHD: Are You An Idea Machine?
Chances are, if you have Adult ADHD, you're an "idea machine"--you come up with great new ideas all the time, maybe several in a day!
What is Hyperactivity in Attention Deficit Hyperactivity Disorder?
Most of the ADHD kids that are seen in a private practice setting are hyperactive kids simply because they get into the most trouble. Their parents are usually pulling their hair out and saying, "We've got to get this child some help.
Attention Deficit Hyperactivity Disorder 101
Introduction
This is a type of mental disorder, which occurs primarily in school-aged children but can also be diagnosed for the first time in the late teens esp., if some of its symptoms are left unnoticed.
How to Get a Good Diagnosis to See If Your Child Has ADHD
Your child's teacher says that you need to find out if your child has ADHD or not. What do you do? Here are some tips from the ADHD Information Library.
Appropriate ADHD Medication For Child - Meds For ADHD Child
Dealing and treating with children suffering from ADHD everyday, I engage a number of parents many of which are despondent about their childs condition, and more often than not, I end up offering consoling and emotional support to the parents than the children. They would often as on what is the best medication for an adhd child. It is a parents nightmare that their child should suffer and be in pain, but such parents forget one very crucial fact with ADHD: it is a readily treatable and curable condition.
ADHD and Depression -- More Common Than Thought
"Thanks for Noticin' Me" says Eeyore. He walks slowly.
Teacher Tips: Improving Compliance in the Classroom with ADHD Students
Thank you to all of our professional educators who dedicate themselves to our children! We know how difficult it can be working with ADHD children, so here are your teacher tips for the week, brought to you by the ADHD Information Library and ADDinSchool.com.
Causes of ADD/ADHD Behavior
Most medical professionals say that the cause of Attention Deficit Disorder and Attention Deficit and Hyperactivity Disorder is genetic. But they also agree that there are other conditions which can lead to lack of focus and hyperactivity. Here are a few of them:
Discover The Best Resources For Adhd
From medical options to alternative solutions, resources for ADHD vary in their availability, variety, and mode of use and extent of effects after treatment and therapy.